KLK3 and cancer: Table 1 summarizes the demographic and clinical characteristics of patients, stratified into cancer (n=72) and non-cancer (n=41) groups. The analysis of serum PSA levels and prostate volume demonstrated significant differences between the cancer and non-cancer groups.